LEADER 02951nam 2200589 a 450 001 9910968398503321 005 20251117065746.0 010 $a1-61324-032-5 035 $a(CKB)2670000000089934 035 $a(EBL)3019436 035 $a(SSID)ssj0000473966 035 $a(PQKBManifestationID)12193218 035 $a(PQKBTitleCode)TC0000473966 035 $a(PQKBWorkID)10466840 035 $a(PQKB)11105688 035 $a(MiAaPQ)EBC3019436 035 $a(Au-PeEL)EBL3019436 035 $a(CaPaEBR)ebr10671001 035 $a(OCoLC)923661076 035 $a(BIP)43287772 035 $a(BIP)28384407 035 $a(EXLCZ)992670000000089934 100 $a20091125d2010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aTreatment of ventricular fibrillation /$fRajiv Sankaranarayanan, Hanney Gonna and Michael James 205 $a1st ed. 210 $aHauppauge, N.Y. $cBioMedical Books$dc2010 215 $a1 online resource (76 p.) 225 1 $aCardiology research and clinical developments 300 $aDescription based upon print version of record. 311 08$a1-60876-850-3 320 $aIncludes bibliographical references (p. [41]-55) and index. 327 $aCardiopulmonary resuscitation -- Drug therapy for ventricular fibrillation -- Automated external defibrillators and public access defibrillation -- Internal cardiovertor defibrillator -- VF ablation. 330 $aThe annual incidence of sudden cardiac deaths in the United States is about 300,000 cases. Ventricular fibrillation (VF) remains an important cause of sudden death both in hospitals and in the community contributing to about half of these cases, although in monitored setting with rapid response times, VF is the presenting rhythm in almost three quarters of these patients. Despite an overall declining trend in the incidence of VF, the management of the arrhythmia remains challenging due to the fact that the event is usually unexpected and almost certainly lethal in the absence of resuscitation within the first few minutes. There has been a dramatic improvement in survival from VF due to the introduction of defibrillation as a part of resuscitation but in a significant proportion of patients, the process of resuscitation proves futile due to lack of return of spontaneous circulation or significant neurological disability caused by cerebral anoxia. 410 0$aCardiology research and clinical developments. 606 $aVentricular fibrillation 615 0$aVentricular fibrillation. 676 $a616.1/28 700 $aSankaranarayanan$b Rajiv$01864950 701 $aGonna$b Hanney$01864951 701 $aJames$b Michael$f1960-$01864952 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910968398503321 996 $aTreatment of ventricular fibrillation$94471934 997 $aUNINA